Sources & References
Peer-reviewed research
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regarding glycaemic control and body weight reduction
Research FAQ
Compound and research-use information
What is GLP-2 TZ?
GLP-2 TZ is a synthetic peptide research compound designed as a dual agonist of the GIP and GLP-1 receptors. It is supplied strictly for laboratory research use.
What is GLP-2 TZ studied for in the research setting?
GLP-2 TZ is used in vitro and in preclinical research as a reference dual GIP / GLP-1 receptor agonist to study incretin-receptor binding and downstream signaling in cell and animal metabolic models. It is a mechanistic research tool only.
What form is Aurevena's GLP-2 TZ supplied in?
GLP-2 TZ is supplied as a lyophilized (freeze-dried) powder. Every batch is tested by independent, accredited U.S. laboratories for purity and identity, with the Certificate of Analysis published on this product page. Store lyophilized peptide cold and protected from light, and avoid repeated freeze-thaw cycles.
Is GLP-2 TZ intended for human use?
No. GLP-2 TZ is sold by Aurevena strictly for laboratory and research use only. It is not a drug, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use, consumption, or for the diagnosis, treatment, cure, or prevention of any disease.





